Pediatrics: Ribavirin and Respiratory Syncytial Virus Infections
AUTOR(ES)
Connor, James
RESUMO
The Scientific Board of the California Medical Association presents the following inventory of items of progress in pediatrics. Each item, in the judgment of a panel of knowledgeable physicians, has recently become reasonably firmly established, both as to scientific fact and important clinical significance. The items are presented in simple epitome and an authoritative reference, both to the item itself and to the subject as a whole, is generally given for those who may be unfamiliar with a particular item. The purpose is to assist busy practitioners, students, research workers, or scholars to stay abreast of these items of progress in pediatrics that have recently achieved a substantial degree of authoritative acceptance, whether in their own field of special interest or another.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1026491Documentos Relacionados
- Exposure of health care workers to ribavirin during therapy for respiratory syncytial virus infections.
- In vivo inhibition of respiratory syncytial virus by ribavirin.
- Effects of ribavirin on respiratory syncytial virus in vitro.
- Metabolism of ribavirin in respiratory syncytial virus-infected and uninfected cells.
- Environmental exposure of primary care personnel to ribavirin aerosol when supervising treatment of infants with respiratory syncytial virus infections.